Tekla Healthcare Investors Statistics
Share Statistics
Tekla Healthcare Investors has - shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 48.17M |
| Failed to Deliver (FTD) Shares | 1.41K |
| FTD / Avg. Volume | 0.68% |
Short Selling Information
The latest short interest is 161.04K, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 161.04K |
| Short % of Shares Out | 0.33% |
| Short % of Float | 0.33% |
| Short Ratio (days to cover) | 1.17 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null.
| PE Ratio | 0 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tekla Healthcare Investors.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.17% and return on capital (ROIC) is 0%.
| Return on Equity (ROE) | 0.17% |
| Return on Assets (ROA) | 0.17% |
| Return on Capital (ROIC) | 0% |
| Revenue Per Employee | - |
| Profits Per Employee | - |
| Employee Count | - |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -2.76% in the last 52 weeks. The beta is 0.74, so Tekla Healthcare Investors's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | -2.76% |
| 50-Day Moving Average | 17.45 |
| 200-Day Moving Average | 17.65 |
| Relative Strength Index (RSI) | 43.63 |
| Average Volume (20 Days) | 205.74K |
Income Statement
In the last 12 months, Tekla Healthcare Investors had revenue of 186.46M and earned 184.95M in profits. Earnings per share was 0.
| Revenue | 186.46M |
| Gross Profit | 186.46M |
| Operating Income | 0 |
| Net Income | 184.95M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 56 in cash and 0 in debt, giving a net cash position of 56.
| Cash & Cash Equivalents | 56 |
| Total Debt | 0 |
| Net Cash | 56 |
| Retained Earnings | 117.95M |
| Total Assets | 1.06B |
| Working Capital | 56 |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
Gross margin is 10.00K%, with operating and profit margins of 0% and 9.92K%.
| Gross Margin | 10.00K% |
| Operating Margin | n/a |
| Pretax Margin | 9.92K% |
| Profit Margin | 9.92K% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HQH pays an annual dividend of $2.48, which amounts to a dividend yield of 15.28%.
| Dividend Per Share | $2.48 |
| Dividend Yield | 15.28% |
| Dividend Growth (YoY) | 63.16% |
| Payout Ratio | 70.25% |
| Earnings Yield | 0% |
| FCF Yield | 0% |
Analyst Forecast
Currently there are no analyst rating for HQH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 343.1 |
| Piotroski F-Score | 3 |